Release Date: 15/05/13 16:28 Summary: Corporate Presentation May 2013 Price Sensitive: No Download Document 3.11MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%